Amjad AlMahameed, MD, MPH, FACP

Amjad AlMahameed, MD, MPH, FACP
Division of Cardiology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Amjad AlMahameed, MD, Division of Cardiology, Beth Israel Deaconess Medical Center, Cardiology-W/Baker 4, One Deaconess Road, Boston, MA 02215; aalmaham@bidmc.harvard.edu

Dr. AlMahameed reported that he has received honoraria for teaching and speaking from Sanofi-Aventis, GlaxoSmithKline, and Pfizer.

Dr. Bhatt reported that he has received honoraria for teaching, speaking, and consulting from Sanofi-Aventis and from Bristol-Myers Squibb.

At the time this article was written, Dr. AlMahameed was on the staff of the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Amjad AlMahameed, MD, MPH, FACP
Division of Cardiology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Amjad AlMahameed, MD, Division of Cardiology, Beth Israel Deaconess Medical Center, Cardiology-W/Baker 4, One Deaconess Road, Boston, MA 02215; aalmaham@bidmc.harvard.edu

Dr. AlMahameed reported that he has received honoraria for teaching and speaking from Sanofi-Aventis, GlaxoSmithKline, and Pfizer.

Dr. Bhatt reported that he has received honoraria for teaching, speaking, and consulting from Sanofi-Aventis and from Bristol-Myers Squibb.

At the time this article was written, Dr. AlMahameed was on the staff of the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Amjad AlMahameed, MD, MPH, FACP
Division of Cardiology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Amjad AlMahameed, MD, Division of Cardiology, Beth Israel Deaconess Medical Center, Cardiology-W/Baker 4, One Deaconess Road, Boston, MA 02215; aalmaham@bidmc.harvard.edu

Dr. AlMahameed reported that he has received honoraria for teaching and speaking from Sanofi-Aventis, GlaxoSmithKline, and Pfizer.

Dr. Bhatt reported that he has received honoraria for teaching, speaking, and consulting from Sanofi-Aventis and from Bristol-Myers Squibb.

At the time this article was written, Dr. AlMahameed was on the staff of the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.